I'm expecting Arris to disclose in their filing, the IPR loss in a subsequent eventsfootnote, and I'm hoping they also disclose an estimate of the related liability in the contingent liability footnote. Both of these footnotes come into play since the IPR decision (last Fri fell in between the 6/30 balance sheet date and the 8/1 date the financials are to be released. Also, there's the possibility of Arris releasing an 8-K tomorrow or Thurs disclosing the IPR loss but that a long shot. We shall see ...